| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |